文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

依鲁替尼对布鲁顿酪氨酸激酶共价抑制机制的计算研究

Computational Investigation of the Covalent Inhibition Mechanism of Bruton's Tyrosine Kinase by Ibrutinib.

作者信息

Barragan Angela M, Ghaby Kyle, Pond Matthew P, Roux Benoît

机构信息

Department of Biochemistry and Molecular Biology, The University of Chicago, 929 E 57th Street, Chicago, Illinois 60637, United States.

Department of Chemistry, The University of Chicago, 5735 S Ellis Avenue, Chicago, Illinois 60637, United States.

出版信息

J Chem Inf Model. 2024 Apr 22;64(8):3488-3502. doi: 10.1021/acs.jcim.4c00023. Epub 2024 Mar 28.


DOI:10.1021/acs.jcim.4c00023
PMID:38546820
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11386585/
Abstract

Covalent inhibitors represent a promising class of therapeutic compounds. Nonetheless, rationally designing covalent inhibitors to achieve a right balance between selectivity and reactivity remains extremely challenging. To better understand the covalent binding mechanism, a computational study is carried out using the irreversible covalent inhibitor of Bruton tyrosine kinase (BTK) ibrutinib as an example. A multi-μs classical molecular dynamics trajectory of the unlinked inhibitor is generated to explore the fluctuations of the compound associated with the kinase binding pocket. Then, the reaction pathway leading to the formation of the covalent bond with the cysteine residue at position 481 via a Michael addition is determined using the string method in collective variables on the basis of hybrid quantum mechanical-molecular mechanical (QM/MM) simulations. The reaction pathway shows a strong correlation between the covalent bond formation and the protonation/deprotonation events taking place sequentially in the covalent inhibition reaction, consistent with a 3-step reaction with transient thiolate and enolates intermediate states. Two possible atomistic mechanisms affecting deprotonation/protonation events from the thiolate to the enolate intermediate were observed: a highly correlated direct pathway involving proton transfer to the C of the acrylamide warhead from the cysteine involving one or a few water molecules and a more indirect pathway involving a long-lived enolate intermediate state following the escape of the proton to the bulk solution. The results are compared with experiments by simulating the long-time kinetics of the reaction using kinetic modeling.

摘要

共价抑制剂是一类很有前景的治疗性化合物。然而,合理设计共价抑制剂以在选择性和反应活性之间实现恰当平衡仍然极具挑战性。为了更好地理解共价结合机制,以布鲁顿酪氨酸激酶(BTK)的不可逆共价抑制剂依鲁替尼为例进行了一项计算研究。生成了未连接抑制剂的多微秒经典分子动力学轨迹,以探索该化合物与激酶结合口袋相关的波动情况。然后,基于混合量子力学 - 分子力学(QM/MM)模拟,使用集体变量中的弦方法确定了通过迈克尔加成与481位半胱氨酸残基形成共价键的反应途径。该反应途径表明共价键形成与共价抑制反应中依次发生的质子化/去质子化事件之间存在很强的相关性,这与具有瞬态硫醇盐和烯醇盐中间态的三步反应一致。观察到了两种可能影响从硫醇盐到烯醇盐中间体去质子化/质子化事件的原子机制:一种是高度相关的直接途径,涉及质子从半胱氨酸通过一个或几个水分子转移到丙烯酰胺弹头的C原子上;另一种是更间接的途径,涉及质子逃逸到本体溶液后形成的长寿命烯醇盐中间态。通过使用动力学模型模拟反应的长时间动力学,将结果与实验进行了比较。

相似文献

[1]
Computational Investigation of the Covalent Inhibition Mechanism of Bruton's Tyrosine Kinase by Ibrutinib.

J Chem Inf Model. 2024-4-22

[2]
Differential impact of BTK active site inhibitors on the conformational state of full-length BTK.

Elife. 2020-11-23

[3]
Exploring 2-Sulfonylpyrimidine Warheads as Acrylamide Surrogates for Targeted Covalent Inhibition: A BTK Story.

J Med Chem. 2024-8-22

[4]
Chemoproteomic Profiling of an Ibrutinib Analogue Reveals its Unexpected Role in DNA Damage Repair.

Chembiochem. 2021-1-5

[5]
Mechanism of covalent binding of ibrutinib to Bruton's tyrosine kinase revealed by QM/MM calculations.

Chem Sci. 2021-1-28

[6]
Covalent docking-driven virtual screening of extensive small-molecule libraries against Bruton tyrosine kinase for the identification of highly selective and potent novel therapeutic candidates.

J Mol Graph Model. 2024-7

[7]
Relative Selectivity of Covalent Inhibitors Requires Assessment of Inactivation Kinetics and Cellular Occupancy: A Case Study of Ibrutinib and Acalabrutinib.

J Pharmacol Exp Ther. 2019-12-23

[8]
Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTK.

Int J Mol Sci. 2020-12-4

[9]
Evaluation of Bruton's Tyrosine Kinase (BTK) inhibition with alternative doses of ibrutinib in subjects with Chronic Lymphocytic Leukemia (CLL).

Cancer Chemother Pharmacol. 2025-2-28

[10]
A non-covalent inhibitor XMU-MP-3 overrides ibrutinib-resistant Btk mutation in B-cell malignancies.

Br J Pharmacol. 2019-12-9

引用本文的文献

[1]
Non-Canonical, Strongly Selective Protein Disulfide Isomerases as Anticancer Therapeutic Targets.

Biomolecules. 2025-8-8

[2]
Challenges and Advances in the Simulation of Targeted Covalent Inhibitors Using Quantum Computing.

J Phys Chem Lett. 2025-8-21

[3]
Kinetic Modeling of Covalent Inhibition: Effects of Rapidly Fluctuating Intermediate States.

bioRxiv. 2025-5-29

[4]
Size-Dependent Target Engagement of Covalent Probes.

J Med Chem. 2025-3-27

本文引用的文献

[1]
Landscape of Tools for Modeling Covalent Modification of Proteins: A Review on Computational Covalent Drug Discovery.

J Phys Chem B. 2023-11-16

[2]
Protein Dynamics and Enzymatic Catalysis.

J Phys Chem B. 2023-3-30

[3]
Controlling Ibrutinib's Conformations about Its Heterobiaryl Axis to Increase BTK Selectivity.

ACS Med Chem Lett. 2023-2-14

[4]
Committor-Consistent Variational String Method.

J Phys Chem Lett. 2022-10-13

[5]
Advances in covalent drug discovery.

Nat Rev Drug Discov. 2022-12

[6]
A Comprehensive Guide for Assessing Covalent Inhibition in Enzymatic Assays Illustrated with Kinetic Simulations.

Curr Protoc. 2022-6

[7]
Optimization of a novel piperazinone series as potent selective peripheral covalent BTK inhibitors.

Bioorg Med Chem Lett. 2022-3-15

[8]
Modeling the Binding and Conformational Energetics of a Targeted Covalent Inhibitor to Bruton's Tyrosine Kinase.

J Chem Inf Model. 2021-10-25

[9]
Mechanism of covalent binding of ibrutinib to Bruton's tyrosine kinase revealed by QM/MM calculations.

Chem Sci. 2021-1-28

[10]
Diversity of Long-Lived Intermediates along the Binding Pathway of Imatinib to Abl Kinase Revealed by MD Simulations.

J Chem Theory Comput. 2020-12-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索